Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...

Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...

Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work ...

In a report released today, Luke Sergott from Barclays maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $235.00. The company’s shares closed yesterday ...

In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands against other non-tech AI opportunities amid DeepSeek selloff. Investors are searching for safer ways to ...

(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) initiated its adjusted earnings and revenue guidance for ...

Among the notable updates, the company announced the appointment of Ms. Janet Huffman, the Chief Financial Officer, to the additional role of Interim Chief Executive Officer. Regarding the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Universal Health Services Inc. Cl B-0.69% $12.06B ...